KEGG   PATHWAY: chx04928
Entry
chx04928                    Pathway                                
Name
Parathyroid hormone synthesis, secretion and action - Capra hircus (goat)
Description
Parathyroid hormone (PTH) is a key regulator of calcium and phosphorus homeostasis. The principal regulators of PTH secretion are extracellular ionized calcium (Ca2+) and 1,25-dihydroxyvitamin D (1,25(OH)2D3). Under conditions of dietary Ca restriction, a decrement in serum Ca concentration induces release of PTH from the parathyroid gland. PTH acts on bone and kidney to stimulate bone turnover, increase the circulating levels of 1,25(OH)2D3 and calcium and inhibit the reabsorption of phosphate from the glomerular filtrate. This hormone exerts its actions via binding to the PTH/PTH-related peptide receptor (PTH1R). PTH1R primarily activates two sub-types of heterotrimeric Gproteins: Gs and Gq , which in turn regulate the activity of adenylyl cyclases and phospholipase C (PLC) that control the flow of cAMP/PKA and IP/PKC signaling cascades, respectively.
Class
Organismal Systems; Endocrine system
Pathway map
chx04928  Parathyroid hormone synthesis, secretion and action
chx04928

Organism
Capra hircus (goat) [GN:chx]
Gene
102185783  CASR; extracellular calcium-sensing receptor precursor [KO:K04612]
100860765  GNAI2; guanine nucleotide-binding protein G(i) subunit alpha-2 [KO:K04630]
102185804  GNAI1; guanine nucleotide-binding protein G(i) subunit alpha-1 [KO:K04630]
108635583  GNAI3; guanine nucleotide-binding protein G(k) subunit alpha [KO:K04630]
102180724  ADCY1; adenylate cyclase type 1 isoform X1 [KO:K08041] [EC:4.6.1.1]
102171922  ADCY2; adenylate cyclase type 2 [KO:K08042] [EC:4.6.1.1]
102169019  ADCY3; adenylate cyclase type 3 [KO:K08043] [EC:4.6.1.1]
102185469  ADCY4; adenylate cyclase type 4 isoform X1 [KO:K08044] [EC:4.6.1.1]
102189798  ADCY5; adenylate cyclase type 5 [KO:K08045] [EC:4.6.1.1]
102169557  ADCY6; adenylate cyclase type 6 [KO:K08046] [EC:4.6.1.1]
102185858  ADCY7; adenylate cyclase type 7 isoform X1 [KO:K08047] [EC:4.6.1.1]
102184919  ADCY8; adenylate cyclase type 8 isoform X1 [KO:K08048] [EC:4.6.1.1]
102188104  ADCY9; adenylate cyclase type 9 [KO:K08049] [EC:4.6.1.1]
102189950  guanine nucleotide-binding protein G(q) subunit alpha [KO:K04634]
102177328  GNA11; guanine nucleotide-binding protein subunit alpha-11 [KO:K04635]
102188148  PLCB1; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1 isoform X1 [KO:K05858] [EC:3.1.4.11]
102180505  PLCB4; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-4 isoform X1 [KO:K05858] [EC:3.1.4.11]
102169966  PLCB2; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2 isoform X1 [KO:K05858] [EC:3.1.4.11]
102189653  PLCB3; 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-3 [KO:K05858] [EC:3.1.4.11]
102188092  ITPR1; inositol 1,4,5-trisphosphate receptor type 1 isoform X1 [KO:K04958]
102170858  ITPR2; inositol 1,4,5-trisphosphate receptor type 2 [KO:K04959]
102184768  ITPR3; inositol 1,4,5-trisphosphate receptor type 3 [KO:K04960]
102175726  GCM1; chorion-specific transcription factor GCMa [KO:K21598]
102188817  GCM2; chorion-specific transcription factor GCMb [KO:K21598]
102181317  MAFB; transcription factor MafB [KO:K09036]
102172821  GATA3; trans-acting T-cell-specific transcription factor GATA-3 isoform X1 [KO:K17895]
100860911  SP1; transcription factor Sp1 [KO:K04684]
102177594  VDR; vitamin D3 receptor [KO:K08539]
108634606  retinoic acid receptor RXR-alpha [KO:K08524]
102189445  RXRB; retinoic acid receptor RXR-beta isoform X1 [KO:K08525]
102170009  RXRG; retinoic acid receptor RXR-gamma isoform X1 [KO:K08526]
102168896  FGF23; fibroblast growth factor 23 [KO:K22428]
102180282  FGFR1; fibroblast growth factor receptor 1 isoform X1 [KO:K04362] [EC:2.7.10.1]
102186879  KL; klotho [KO:K14756] [EC:3.2.1.31]
102186040  MAPK1; mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]
102188824  MAPK3; mitogen-activated protein kinase 3 [KO:K04371] [EC:2.7.11.24]
102188309  EGR1; early growth response protein 1 [KO:K09203]
102168368  PTH; parathyroid hormone isoform X2 [KO:K05261]
102176607  SGK1; serine/threonine-protein kinase Sgk1 isoform X1 [KO:K13302] [EC:2.7.11.1]
102188027  WNK3; serine/threonine-protein kinase WNK3 isoform X1 [KO:K08867] [EC:2.7.11.1]
102191045  WNK2; LOW QUALITY PROTEIN: serine/threonine-protein kinase WNK2 [KO:K08867] [EC:2.7.11.1]
102172797  WNK1; serine/threonine-protein kinase WNK1 isoform X1 [KO:K08867] [EC:2.7.11.1]
102184280  WNK4; serine/threonine-protein kinase WNK4 isoform X1 [KO:K08867] [EC:2.7.11.1]
102176738  STK39; STE20/SPS1-related proline-alanine-rich protein kinase [KO:K08835] [EC:2.7.11.1]
102185045  OXSR1; serine/threonine-protein kinase OSR1 isoform X1 [KO:K08835] [EC:2.7.11.1]
102188619  SLC12A3; solute carrier family 12 member 3 isoform X1 [KO:K14426]
100860907  PTHLH; parathyroid hormone-related protein precursor [KO:K22608]
102183924  PTH1R; parathyroid hormone/parathyroid hormone-related peptide receptor isoform X1 [KO:K04585]
102180890  PRKCA; protein kinase C alpha type [KO:K02677] [EC:2.7.11.13]
102172114  PRKCB; protein kinase C beta type isoform X2 [KO:K19662] [EC:2.7.11.13]
102175984  PRKCG; protein kinase C gamma type [KO:K19663] [EC:2.7.11.13]
102180917  TRPV5; transient receptor potential cation channel subfamily V member 5 [KO:K04974]
100860858  SLC34A1; sodium-dependent phosphate transport protein 2A isoform X1 [KO:K14683]
100861296  SLC34A2; sodium-dependent phosphate transport protein 2B [KO:K14683]
102187945  SLC34A3; sodium-dependent phosphate transport protein 2C isoform X1 [KO:K14683]
106503247  SLC9A3R1; Na(+)/H(+) exchange regulatory cofactor NHE-RF1 [KO:K13365]
102188874  guanine nucleotide-binding protein G(s) subunit alpha isoforms short isoform X1 [KO:K04632]
108633189  neuroendocrine secretory protein 55 [KO:K04632]
102183183  PDE4D; cAMP-specific 3',5'-cyclic phosphodiesterase 4D isoform X2 [KO:K13293] [EC:3.1.4.53]
102188762  PDE4A; cAMP-specific 3',5'-cyclic phosphodiesterase 4A isoform X1 [KO:K13293] [EC:3.1.4.53]
102180558  PDE4B; cAMP-specific 3',5'-cyclic phosphodiesterase 4B isoform X2 [KO:K13293] [EC:3.1.4.53]
102171320  PDE4C; cAMP-specific 3',5'-cyclic phosphodiesterase 4C isoform X1 [KO:K13293] [EC:3.1.4.53]
102173379  PRKACA; cAMP-dependent protein kinase catalytic subunit alpha [KO:K04345] [EC:2.7.11.11]
102168790  PRKACB; cAMP-dependent protein kinase catalytic subunit beta isoform X1 [KO:K04345] [EC:2.7.11.11]
102170758  25-hydroxyvitamin D-1 alpha hydroxylase, mitochondrial [KO:K07438] [EC:1.14.15.18]
102178921  1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial isoform X1 [KO:K07436] [EC:1.14.15.16]
102180703  MEF2A; myocyte-specific enhancer factor 2A [KO:K09260]
102175290  MEF2C; myocyte-specific enhancer factor 2C [KO:K04454]
102174260  MEF2D; myocyte-specific enhancer factor 2D [KO:K09262]
102185686  SOST; sclerostin [KO:K16834]
102169808  NR4A2; nuclear receptor subfamily 4 group A member 2 isoform X1 [KO:K08558]
102185811  NACA; nascent polypeptide-associated complex subunit alpha [KO:K03626]
108636405  JUND; transcription factor jun-D [KO:K04449]
100861188  BGLAP; osteocalcin [KO:K22609]
106503755  LRP5; low-density lipoprotein receptor-related protein 5 isoform X1 [KO:K03068]
102177417  LRP6; low-density lipoprotein receptor-related protein 6 isoform X1 [KO:K03068]
102186065  CREB1; cyclic AMP-responsive element-binding protein 1 isoform X1 [KO:K05870]
102180634  ATF2; LOW QUALITY PROTEIN: cyclic AMP-dependent transcription factor ATF-2 [KO:K04450]
102180221  CREB3; cyclic AMP-responsive element-binding protein 3 isoform X1 [KO:K09048]
102174829  CREB3L3; cyclic AMP-responsive element-binding protein 3-like protein 3 isoform X1 [KO:K09048]
102183745  CREB3L4; cyclic AMP-responsive element-binding protein 3-like protein 4 isoform X1 [KO:K09048]
102183893  CREB3L1; cyclic AMP-responsive element-binding protein 3-like protein 1 [KO:K09048]
102170199  CREB3L2; cyclic AMP-responsive element-binding protein 3-like protein 2 [KO:K09048]
102185072  ATF4; cyclic AMP-dependent transcription factor ATF-4 [KO:K04374]
102190378  CREB5; cyclic AMP-responsive element-binding protein 5 isoform X1 [KO:K09047]
102171671  ATF6B; cyclic AMP-dependent transcription factor ATF-6 beta isoform X1 [KO:K09049]
102176335  TNFSF11; tumor necrosis factor ligand superfamily member 11 [KO:K05473]
100861254  BCL2; apoptosis regulator Bcl-2 [KO:K02161]
102179898  CDKN1A; cyclin-dependent kinase inhibitor 1 [KO:K06625]
102171520  FOS; proto-oncogene c-Fos [KO:K04379]
102183278  RUNX2; runt-related transcription factor 2 isoform X1 [KO:K09278]
102170069  MMP13; collagenase 3 [KO:K07994] [EC:3.4.24.-]
102185175  GNA12; guanine nucleotide-binding protein subunit alpha-12 isoform X1 [KO:K04346]
102170818  GNA13; guanine nucleotide-binding protein subunit alpha-13 [KO:K04639]
102180150  ARHGEF1; rho guanine nucleotide exchange factor 1 isoform X1 [KO:K12330]
102172018  ARHGEF11; rho guanine nucleotide exchange factor 11 isoform X1 [KO:K12331]
102184845  AKAP13; A-kinase anchor protein 13 isoform X1 [KO:K16529]
102181169  RHOA; transforming protein RhoA [KO:K04513]
102174434  PLD1; phospholipase D1 isoform X5 [KO:K01115] [EC:3.1.4.4]
102176556  PLD2; phospholipase D2 [KO:K01115] [EC:3.1.4.4]
102189417  ARRB1; beta-arrestin-1 isoform X3 [KO:K04439]
102186433  ARRB2; beta-arrestin-2 isoform X1 [KO:K04439]
102169370  ARAF; serine/threonine-protein kinase A-Raf isoform X1 [KO:K08845] [EC:2.7.11.1]
102174360  BRAF; serine/threonine-protein kinase B-raf isoform X1 [KO:K04365] [EC:2.7.11.1]
108638619  RAF1; RAF proto-oncogene serine/threonine-protein kinase [KO:K04366] [EC:2.7.11.1]
102190520  MAP2K1; dual specificity mitogen-activated protein kinase kinase 1 isoform X4 [KO:K04368] [EC:2.7.12.2]
100861171  MMP14; matrix metalloproteinase-14 precursor [KO:K07763] [EC:3.4.24.80]
102168287  MMP15; matrix metalloproteinase-15 [KO:K07995] [EC:3.4.24.-]
102170337  MMP16; matrix metalloproteinase-16 [KO:K07996] [EC:3.4.24.-]
102173594  MMP17; matrix metalloproteinase-17 [KO:K07997] [EC:3.4.24.-]
102176054  MMP24; matrix metalloproteinase-24 [KO:K08002] [EC:3.4.24.-]
102177582  MMP25; matrix metalloproteinase-25 [KO:K08003] [EC:3.4.24.-]
102185462  HBEGF; proheparin-binding EGF-like growth factor [KO:K08523]
102172767  EGFR; epidermal growth factor receptor [KO:K04361] [EC:2.7.10.1]
Compound
C00009  Orthophosphate
C00020  AMP
C00076  Calcium cation
C00165  Diacylglycerol
C00575  3',5'-Cyclic AMP
C00698  Cl-
C01245  D-myo-Inositol 1,4,5-trisphosphate
C01330  Sodium cation
C01561  Calcidiol
C01673  Calcitriol
C18231  Calcitetrol
Reference
  Authors
Khundmiri SJ, Murray RD, Lederer E
  Title
PTH and Vitamin D.
  Journal
Compr Physiol 6:561-601 (2016)
DOI:10.1002/cphy.c140071
Reference
  Authors
Bastepe M, Turan S, He Q
  Title
Heterotrimeric G proteins in the control of parathyroid hormone actions.
  Journal
J Mol Endocrinol 58:R203-R224 (2017)
DOI:10.1530/JME-16-0221
Reference
  Authors
Vilardaga JP, Romero G, Friedman PA, Gardella TJ
  Title
Molecular basis of parathyroid hormone receptor signaling and trafficking: a family B GPCR paradigm.
  Journal
Cell Mol Life Sci 68:1-13 (2011)
DOI:10.1007/s00018-010-0465-9
Reference
  Authors
Naveh-Many T, Silver J
  Title
Transcription factors that determine parathyroid development power PTH expression.
  Journal
Kidney Int 93:7-9 (2018)
DOI:10.1016/j.kint.2017.08.026
Reference
  Authors
Han SI, Tsunekage Y, Kataoka K
  Title
Gata3 cooperates with Gcm2 and MafB to activate parathyroid hormone gene expression by interacting with SP1.
  Journal
Mol Cell Endocrinol 411:113-20 (2015)
DOI:10.1016/j.mce.2015.04.018
Reference
  Authors
Ferre S, Hoenderop JG, Bindels RJ
  Title
Sensing mechanisms involved in Ca2+ and Mg2+ homeostasis.
  Journal
Kidney Int 82:1157-66 (2012)
DOI:10.1038/ki.2012.179
Reference
  Authors
Komaba H, Fukagawa M
  Title
FGF23-parathyroid interaction: implications in chronic kidney disease.
  Journal
Kidney Int 77:292-8 (2010)
DOI:10.1038/ki.2009.466
Reference
  Authors
Bilezikian JP, Cusano NE, Khan AA, Liu JM, Marcocci C, Bandeira F
  Title
Primary hyperparathyroidism.
  Journal
Nat Rev Dis Primers 2:16033 (2016)
DOI:10.1038/nrdp.2016.33
Reference
  Authors
de Groot T, Kovalevskaya NV, Verkaart S, Schilderink N, Felici M, van der Hagen EA, Bindels RJ, Vuister GW, Hoenderop JG
  Title
Molecular mechanisms of calmodulin action on TRPV5 and modulation by parathyroid hormone.
  Journal
Mol Cell Biol 31:2845-53 (2011)
DOI:10.1128/MCB.01319-10
Reference
  Authors
Hernando N, Wagner C, Biber J, Murer H
  Title
Kidney kinase network regulates renal ion cotransport.
  Journal
J Clin Invest 117:3179-82 (2007)
DOI:10.1172/JCI33859
Reference
  Authors
Wang B, Means CK, Yang Y, Mamonova T, Bisello A, Altschuler DL, Scott JD, Friedman PA
  Title
Ezrin-anchored protein kinase A coordinates phosphorylation-dependent disassembly of a NHERF1 ternary complex to regulate hormone-sensitive phosphate transport.
  Journal
J Biol Chem 287:24148-63 (2012)
DOI:10.1074/jbc.M112.369405
Reference
  Authors
Crenshaw TD, Rortvedt LA, Hassen Z
  Title
Triennial Growth Symposium: a novel pathway for vitamin D-mediated phosphate homeostasis: implications for skeleton growth and mineralization.
  Journal
J Anim Sci 89:1957-64 (2011)
DOI:10.2527/jas.2010-3411
Reference
  Authors
Zierold C, Mings JA, DeLuca HF
  Title
Parathyroid hormone regulates 25-hydroxyvitamin D(3)-24-hydroxylase mRNA by altering its stability.
  Journal
Proc Natl Acad Sci U S A 98:13572-6 (2001)
DOI:10.1073/pnas.241516798
Reference
  Authors
Kramer I, Keller H, Leupin O, Kneissel M
  Title
Does osteocytic SOST suppression mediate PTH bone anabolism?
  Journal
Trends Endocrinol Metab 21:237-44 (2010)
DOI:10.1016/j.tem.2009.12.002
Reference
  Authors
Leupin O, Kramer I, Collette NM, Loots GG, Natt F, Kneissel M, Keller H
  Title
Control of the SOST bone enhancer by PTH using MEF2 transcription factors.
  Journal
J Bone Miner Res 22:1957-67 (2007)
DOI:10.1359/jbmr.070804
Reference
  Authors
Meir T, Durlacher K, Pan Z, Amir G, Richards WG, Silver J, Naveh-Many T
  Title
Parathyroid hormone activates the orphan nuclear receptor Nurr1 to induce FGF23 transcription.
  Journal
Kidney Int 86:1106-15 (2014)
DOI:10.1038/ki.2014.215
Reference
  Authors
Pellicelli M, Hariri H, Miller JA, St-Arnaud R
  Title
Lrp6 is a target of the PTH-activated alphaNAC transcriptional coregulator.
  Journal
Biochim Biophys Acta 1861:61-71 (2018)
DOI:10.1016/j.bbagrm.2018.01.008
Reference
  Authors
Fu Q, Jilka RL, Manolagas SC, O'Brien CA
  Title
Parathyroid hormone stimulates receptor activator of NFkappa B ligand and inhibits osteoprotegerin expression via protein kinase A activation of cAMP-response element-binding protein.
  Journal
J Biol Chem 277:48868-75 (2002)
DOI:10.1074/jbc.M208494200
Reference
  Authors
O'Brien CA
  Title
Control of RANKL gene expression.
  Journal
Bone 46:911-9 (2010)
DOI:10.1016/j.bone.2009.08.050
Reference
  Authors
Jilka RL
  Title
Molecular and cellular mechanisms of the anabolic effect of intermittent PTH.
  Journal
Bone 40:1434-46 (2007)
DOI:10.1016/j.bone.2007.03.017
Reference
PMID:8810350
  Authors
Pearman AT, Chou WY, Bergman KD, Pulumati MR, Partridge NC
  Title
Parathyroid hormone induces c-fos promoter activity in osteoblastic cells through phosphorylated cAMP response element (CRE)-binding protein binding to the major CRE.
  Journal
J Biol Chem 271:25715-21 (1996)
DOI:10.1074/jbc.271.41.25715
Reference
  Authors
Boumah CE, Selvamurugan N, Partridge NC
  Title
Transcription in the osteoblast: regulatory mechanisms utilized by parathyroid hormone and transforming growth factor-beta.
  Journal
Prog Nucleic Acid Res Mol Biol 80:287-321 (2005)
DOI:10.1016/S0079-6603(05)80007-8
Reference
  Authors
Hess J, Porte D, Munz C, Angel P
  Title
AP-1 and Cbfa/runt physically interact and regulate parathyroid hormone-dependent MMP13 expression in osteoblasts through a new osteoblast-specific element 2/AP-1  composite element.
  Journal
J Biol Chem 276:20029-38 (2001)
DOI:10.1074/jbc.M010601200
Reference
  Authors
Singh AT, Gilchrist A, Voyno-Yasenetskaya T, Radeff-Huang JM, Stern PH
  Title
G alpha12/G alpha13 subunits of heterotrimeric G proteins mediate parathyroid hormone activation of phospholipase D in UMR-106 osteoblastic cells.
  Journal
Endocrinology 146:2171-5 (2005)
DOI:10.1210/en.2004-1283
Reference
  Authors
Ahmed I, Gesty-Palmer D, Drezner MK, Luttrell LM
  Title
Transactivation of the epidermal growth factor receptor mediates parathyroid hormone and prostaglandin F2 alpha-stimulated mitogen-activated protein kinase activation in cultured transgenic murine osteoblasts.
  Journal
Mol Endocrinol 17:1607-21 (2003)
DOI:10.1210/me.2002-0040
Reference
  Authors
Sneddon WB, Yang Y, Ba J, Harinstein LM, Friedman PA
  Title
Extracellular signal-regulated kinase activation by parathyroid hormone in distal tubule cells.
  Journal
Am J Physiol Renal Physiol 292:F1028-34 (2007)
DOI:10.1152/ajprenal.00288.2006
Reference
  Authors
Agoro R, Ni P, Noonan ML, White KE
  Title
Osteocytic FGF23 and Its Kidney Function.
  Journal
Front Endocrinol (Lausanne) 11:592 (2020)
DOI:10.3389/fendo.2020.00592
Reference
  Authors
Erben RG, Andrukhova O
  Title
FGF23-Klotho signaling axis in the kidney.
  Journal
Bone 100:62-68 (2017)
DOI:10.1016/j.bone.2016.09.010
Reference
  Authors
Murillo-de-Ozores AR, Rodriguez-Gama A, Carbajal-Contreras H, Gamba G, Castaneda-Bueno M
  Title
WNK4 kinase: from structure to physiology.
  Journal
Am J Physiol Renal Physiol 320:F378-F403 (2021)
DOI:10.1152/ajprenal.00634.2020
Related
pathway
chx04012  ErbB signaling pathway
chx04020  Calcium signaling pathway
chx04024  cAMP signaling pathway
chx04310  Wnt signaling pathway
chx04380  Osteoclast differentiation
chx04961  Endocrine and other factor-regulated calcium reabsorption
KO pathway
ko04928   
LinkDB

DBGET integrated database retrieval system